Mirae Asset Capital

MorphMind

Modulim

Motley Bio

Mesa Verde Venture Partners

Montgomery County Economic Development Corporation

Mainline Investment

MDV

Medmine Partners pty Ltd

Millennium Management LLC

Morgan Capital

Morgan Prestwich

Microbion Corporation

Multispan Inc

Mezzion Pharmaceuticals, Inc

Mindgram

Mass Medical Angels

Mango Sciences

Murck-Neuroscience LLC

Maverick Life Sciences LLC

mbiomics

Moberg Pharma

Mobius Medical

Micot Pharmaceutical Technology Co., Ltd

Mispro Biotech Services

MaRS Discovery District

Molecule AG

Matrix Partners China

Merlin Biotech, Inc.

Movac

Mayewell Capital, LLC

MEDA Ventures

MEDIS

Meiji Seika Pharma Co., Ltd.

MeiraGTx

METiS Techbio

Micron Biomedical, Inc.

Microvascular Therapeutics, LLC

Mitsubishi Corporation

Medera

MediMabBio

MEDISO

Meritage Technologies Inc.

Mucpharm Pty Ltd

Megapharm Ltd

MindRank

Mitsubishi UFJ Capital Co., Ltd

Monash University

Multus Biotechnology

Merrill Lynch Wealth Management_Maylan Studart

Meta Pharmaceuticals (HK) Limited

MDB Capital Group

myTomorrows

Mitsui & Co. Global Investment Inc.

MacroLink

MedAbome, Inc.

Madera Therapeutics

Magnet Ventures

MAIA Biotechnology, Inc.

Mana.bio

Manaolana Oncology

Marigold Investment Management

MarksMan Healthcare Communications

Maruho Israel Innovation Fund

Matisse Pharmaceuticals B.V.

Mayo Clinic / Discovery Oasis

MD Anderson Cancer Center

MEDIC Life Sciences

Medical Excellence Capital

MedinCell SA

MediWound

Mérieux Equity Partners

Methuselah Fund_Marie

MicuRx Pharmaceuticals, Inc.

Mid Atlantic Bio Angels

Midwest BioCapital

MindImmune

Mirum Pharmaceuticals, Inc.

MitoChem Therapeutics

Mizuho Securities

MLAB Biosciences

MME, an Indegene PRMA business

Model Medicines

Monod Bio, Inc.

Morphocell Technologies

MP Healthcare Venture Management, Inc

MQB Partners

MSQ Ventures

Multimeric Biotherapeutics, Inc.

MultiOmic Health

MV CORP SERVICES

MVM Life Science Partners LLP